Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
Top Cited Papers
Open Access
- 8 April 2020
- journal article
- editorial
- Published by Elsevier BV in Canadian Journal of Cardiology
- Vol. 36 (6), 948-951
- https://doi.org/10.1016/j.cjca.2020.04.003
Abstract
No abstract availableKeywords
Funding Information
- Biosense Webster
- Abbott Laboratories
- Medtronic
This publication has 2 references indexed in Scilit:
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020